Patrick T. McGann

3.4k total citations
92 papers, 2.0k citations indexed

About

Patrick T. McGann is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Patrick T. McGann has authored 92 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Genetics, 76 papers in Hematology and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Patrick T. McGann's work include Hemoglobinopathies and Related Disorders (82 papers), Iron Metabolism and Disorders (68 papers) and Blood groups and transfusion (19 papers). Patrick T. McGann is often cited by papers focused on Hemoglobinopathies and Related Disorders (82 papers), Iron Metabolism and Disorders (68 papers) and Blood groups and transfusion (19 papers). Patrick T. McGann collaborates with scholars based in United States, United Kingdom and Canada. Patrick T. McGann's co-authors include Russell E. Ware, Alexandra Power‐Hays, Brígida Santos, Thad A. Howard, Angela C. Weyand, Adam Lane, Léon Tshilolo, Min Dong, Peter Olupot‐Olupot and Teresa Latham and has published in prestigious journals such as New England Journal of Medicine, JAMA and Blood.

In The Last Decade

Patrick T. McGann

85 papers receiving 2.0k citations

Peers

Countries citing papers authored by Patrick T. McGann

Since Specialization

Citations

This map shows the geographic impact of Patrick T. McGann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick T. McGann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick T. McGann more than expected).

Fields of papers citing papers by Patrick T. McGann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick T. McGann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick T. McGann. The network helps show where Patrick T. McGann may publish in the future.

Co-authorship network of co-authors of Patrick T. McGann

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick T. McGann. A scholar is included among the top collaborators of Patrick T. McGann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick T. McGann. Patrick T. McGann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations 2025 ·Blood Advances ·Alexandra Power‐Hays, Kathryn McElhinney, Thomas N. Williams, George Mochamah, Peter Olupot‐Olupot, (unknown), Marvin Reid, Angela Rankine‐Mullings, Robert O. Opoka, Chandy C. John, Patrick T. McGann, Charles T. Quinn, Nieko Punt, Luke R. Smart, Susan E. Stuber, Teresa Latham, Alexander A. Vinks, Russell E. Ware	0
2	Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell disease 2025 ·Blood Advances ·(unknown), (unknown), Patrick T. McGann	2
3	Sickle cell trait does not cause “sickle cell crisis” leading to exertion-related death: a systematic review 2025 ·Blood ·Lachelle D. Weeks, Allecia M. Wilson, Rakhi P. Naik, Yvonne A. Efebera, M. Hassan Murad, Anjlee Mahajan, Patrick T. McGann, Madeleine Verhovsek, Angela C. Weyand, Ahmar U. Zaidi, Michael R. DeBaun, (unknown), Roger A. Mitchell	3
4	How We Approach Contraception for Adolescents and Young Adults With Sickle Cell Disease 2025 ·Pediatric Blood & Cancer ·(unknown), Patrick T. McGann, (unknown)	0
5	Trends in Sickle Cell Disease Mortality: 1979–2020 2024 ·PEDIATRICS ·(unknown), Patrick T. McGann	4
6	Individualized, PK-Guided Dosing of Hydroxyurea for Young Children with Sickle Cell Anemia: Final Results from the Hydroxyurea Optimization through Precision Study (HOPS) 2024 ·Blood ·(unknown), (unknown), Matthew M. Heeney, Connie M. Piccone, Omar Niss, Charles T. Quinn, (unknown), (unknown), (unknown), (unknown), (unknown), Min Dong, Kathryn McElhinney, (unknown), Patrick T. McGann	0
7	Fostering a healthier generation of children with sickle cell disease through advancements in care 2024 ·Pediatric Research ·(unknown), (unknown), Patrick T. McGann	2
8	Prevalence of Iron Deficiency and Iron-Deficiency Anemia in US Females Aged 12-21 Years, 2003-2020 2023 ·JAMA ·Angela C. Weyand, Alexander Chaitoff, Gary L. Freed, Michelle Sholzberg, Sung Won Choi, Patrick T. McGann	42
9	Buprenorphine for Pain Management in Patients with Sickle Cell Disease from Infancy to Adulthood (SA309A) 2023 ·Journal of Pain and Symptom Management ·Tara M. Brown, (unknown), Angela Anderson, Patrick T. McGann	1
10	Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia 2022 ·Pediatric Blood & Cancer ·Susan E. Creary, (unknown), Joseph Stanek, Kathryn King, Patrick T. McGann, Sarah H. O’Brien, Robert I. Liem, Jane L. Holl, Sherif M. Badawy	8
11	Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries 2022 ·BMJ Open ·Natasha M. Archer, Baba Inusa, Julie Makani, Siana Nkya, Léon Tshilolo, Venée N. Tubman, Patrick T. McGann, Emmanuela E. Ambrose, Natalie Henrich, Jonathan Spector, Kwaku Ohene‐Frempong	18
12	Hydroyxurea improves cerebral oxygen saturation in children with sickle cell anemia 2021 ·American Journal of Hematology ·(unknown), Charles T. Quinn, Omar Niss, (unknown), Min Dong, Alexander A. Vinks, Patrick T. McGann	2
13	How I approach disease‐modifying therapy in children with sickle cell disease in an era of novel therapies 2021 ·Pediatric Blood & Cancer ·(unknown), Patrick T. McGann	2
14	Implementation of near‐universal hydroxyurea uptake among children with sickle cell anemia: A single‐center experience 2021 ·Pediatric Blood & Cancer ·(unknown), (unknown), Omar Niss, (unknown), (unknown), Theodosia A. Kalfa, Punam Malik, Charles T. Quinn, Russell E. Ware, Patrick T. McGann	10
15	The Effects of Armed Conflict on Children 2018 ·PEDIATRICS ·Sherry Shenoda, Ayesha Kadir, (unknown), Jeffrey Goldhagen, (unknown), Parminder S. Suchdev, Kevin Chan, Cynthia R. Howard, Patrick T. McGann, Nicole E. St Clair, Katherine Yun, Linda D. Arnold	67
16	The Role of Pediatricians in Global Health 2018 ·PEDIATRICS ·Parminder S. Suchdev, Cynthia R. Howard, (unknown), Kevin Chan, Patrick T. McGann, Nicole E. St Clair, Katherine Yun, Linda D. Arnold	16
17	Prevention of Acute Chest Syndrome By Implementing a Standardized Process to Improve Incentive Spirometry Use in Hospitalized Patients with Sickle Cell Disease 2017 ·Blood ·Omar Niss, (unknown), (unknown), (unknown), (unknown), (unknown), J. ROLLINS, Patrick T. McGann, Karen Kalinyak	3
18	Clinical Features of β-Thalassemia and Sickle Cell Disease 2017 ·Advances in experimental medicine and biology ·Patrick T. McGann, Alecia Nero, Russell E. Ware	20
19	Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis 2016 ·Blood Cells Molecules and Diseases ·Omar Niss, Satheesh Chonat, Neha Dagaonkar, (unknown), (unknown), Zora R. Rogers, Patrick T. McGann, (unknown), (unknown), Kejian Zhang, Theodosia A. Kalfa	49
20	Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: Results from the BABY‐HUG phase III clinical trial 2011 ·Pediatric Blood & Cancer ·Patrick T. McGann, Jonathan M. Flanagan, Thad A. Howard, Stephen D. Dertinger, Jin He, Anita S. Kulharya, Bruce Thompson, Russell E. Ware, (unknown)	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact